Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Affymetrix, Inc.    AFFX   US00826T1088

AFFYMETRIX, INC. (AFFX)

20
Delayed Quote. Delayed Nasdaq - 09/02 04:00:01 pm
8.65 USD   -0.23%
5d ago AFFYMETRIX : Assigned Patent
7d ago AFFYMETRIX : Patent Issued for Methods for Genotyping Selected Polymorphism
08/26 AFFYMETRIX : Assigned Patent
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and sells products and services for genetic analysis

Affymetrix, Inc. provides life science and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.

It develops, manufactures and sells products and services for genetic analysis to the genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies.

The company operates through two segments: Affymetrix Core and eBioscience.

The Affymetrix Core segment is divided into four business units, namely Expression, Genetic Analysis and Clinical Applications, Life Science Reagents and Corporate.

The Expression business unit develops and markets the company's GeneChip gene expression products and services; Genetic Analysis and Clinical Applications business unit develops and markets the company's genotyping, such as the Axiom product line and arrays with clinical research applications, such as the CytoScan cytogenetics arrays; Life Science Reagents business unit develops and sells reagents, enzymes, purification kits and biochemical's used by life science researchers and Corporate business unit is comprised of revenue from royalty arrangements, and field revenue from services provided to customers by the company . The eBioscience segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses.

The company was founded by Stephen P. A. Fodor in 1991 and is headquartered in Santa Clara, CA.
Managers
NameAgeSinceTitle
Stephen P. A. Fodor, PhD601991Chairman
Douglas Farrell--Treasurer & Vice President-Investor Relations
Robert H. Trice Jr., PhD672006Independent Director
Robert Paul Wayman, MBA682007Independent Director
Gary S. Guthart, PhD482009Independent Director
Jami K. Dover Nachtsheim552010Lead Independent Director
Nelson C. Chan, MBA522010Independent Director
Franklin R. Witney, PhD602011President, Chief Executive Officer & Director
Mindy Lee-Olsen--VP-Marketing Services & Media Relations Contact
David A. Weber602011Chief Commercial Officer & Executive VP
Shareholders
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Diagnostics & Testing
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
EUROFINS SCIENTIF..
MIRACA HOLDINGS I..
DA AN GENE CO., L..
AFFYMETRIX, INC.
INNATE PHARMA
VERACYTE INC
MEDICAL&BIOLOGICA..
-
MEDIBIC GROUP
-
VERMILLION, INC.
-
EPIGENOMICS AG
TRANS GENIC INC.
-
SOIKEN HOLDINGS I..
-
VIMTA LABS LTD
-
EXIQON A/S
ALLENEX AB
-
RESPONSE GENETICS..
-
DNA CHIP RESEARCH..
-
AB-BIOTICS SA
-
INA RESEARCH INC
-
NORDA ASA
-
Sector Biotechnology & Medical Research
Company contact information
Affymetrix, Inc.
3420 Central Expressway
Santa Clara, CA 95051

Phone : +1.408.731.5000
Fax : +1.408.731.5380
Web : www.affymetrix.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF